{
    "SPADE_UN_19660": {
        "Sequence Information": {
            "Peptide Name": "Wollamide B [Orn6r]",
            "Sequence": "NVLLWR",
            "Sequence Length": 6,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Solid-Phase Synthesis and Antibacterial Activity of Cyclohexapeptide Wollamide B Analogs.",
                    "Pubmed ID": "29431987",
                    "Reference": "ACS Comb Sci. 2018;:",
                    "Author": "Tsutsumi LS, Elmore JM, Dang UT, Wallace MJ, Marreddy R, Lee RB, Hurdle JG, Lee RE, Sun D",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29431987"
                },
                {
                    "Title": "Structure-Activity Relationships of Wollamide Cyclic Hexapeptides with Activity against Drug-Resistant and Intracellular Mycobacterium tuberculosis.",
                    "Pubmed ID": "30602509",
                    "Reference": "Antimicrob Agents Chemother. 2019;63:e01773-18",
                    "Author": "Khalil ZG, Hill TA, De Leon Rodriguez LM, Lohman RJ, Hoang HN, Reiling N, Hillemann D, Brimble MA, Fairlie DP, Blumenthal A, Capon RJ",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30602509"
                }
            ],
            "Mass": 799.96,
            "PI": 9.75,
            "Net Charge": 1,
            "Hydrophobicity": 0.48,
            "Frequent Amino Acids": "LNR",
            "Absent Amino Acids": "ACDEFGHIKMOPQSTUY",
            "Basic Residues": 1,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 3,
            "Polar Residues": 3,
            "Positive Residues": 1,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_19660",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_03566",
                    "Similarity": 1.0,
                    "Sequence": "GFGSLGKALRLGANVL"
                },
                {
                    "SPADE_ID": "SPADE_N_03576",
                    "Similarity": 1.0,
                    "Sequence": "GFGSLLGKALRLGANVL"
                },
                {
                    "SPADE_ID": "SPADE_N_12075",
                    "Similarity": 1.0,
                    "Sequence": "NVLLW"
                }
            ],
            "Hemolytic Activity": "Vero cells:IC50=193.7 µg/ml",
            "Target Organism": "Mycobacterium tuberculosis H37Rv(MIC=6.25µg/ml),Staphylococcus aureus ATCC 29213(MIC=50µg/ml),Clostridioides difficile R20291(MIC=32µg/ml),Staphylococcus epidermidis ATCC 14990(MIC=50µg/ml),Enterococcus faecalis ATCC 33186(MIC=50µg/ml),Enterococcus faecium ATCC 19434(MIC=50µg/ml),Bacillus cereus ATCC 14579(MIC=50µg/ml),Escherichia coli K-12(MIC=>200µg/ml),Escherichia coli deltatolC(MIC=200µg/ml),Mycobacterium tuberculosis H37Rv(MIC90=2.97µM),Mycobacterium tuberculosis H37Rv(IC50=1.03µM),Mycobacterium tuberculosis H37Ra(MIC90=0.33µM),Mycobacterium tuberculosis H37Ra(IC50=0.13µM),Mycobacterium tuberculosis HN878(MIC90=0.99µM),Mycobacterium tuberculosis HN878(IC50=0.66µM),Mycobacterium tuberculosis HN353(MIC90=2.97µM),Mycobacterium tuberculosis HN353(IC50=0.59µM),Mycobacterium tuberculosis CDC1551(MIC90=0.99µM),Mycobacterium tuberculosis CDC1551(IC50=0.71µM),Human colon adenocarcinoma SW620(IC50=>30µM),Human lung carcinoma NCI-H460(IC50=>30µM),Human hepatocellular carcinoma HepG2(IC50=>30µM)"
        }
    }
}